Hemangioblastoma
What is Hemangioblastoma?
Overview
A hemangioblastoma is a rare type of benign brain tumor that originates from blood vessels in the central nervous system. These tumors most commonly occur in the posterior fossa, which is the region at the back of the brain near the cerebellum, but they can also develop in the spinal cord.
Hemangioblastomas are composed of a central mass of blood vessels surrounded by supportive cells called stromal cells and typically have a solid and a cystic component.
Hemangioblastomas may also occur in patients with Von Hippel-Lindau (VHL) disease, an inherited autosomal dominant condition in which both benign and malignant tumors develop including retinal angiomas, pancreatic cysts, pheochromocytomas and renal cell carcinomas.
Symptomatic hemangioblastomas generally require surgical removal with minimally invasive keyhole approaches.
Who is Affected?
Hemangioblastomas can occur at any age but are most often diagnosed in adults between ages 30 and 50. They affect men and women equally. Individuals with VHL disease are at higher risk and may develop multiple hemangioblastomas over their lifetime.
Hemangioblastoma Symptoms & Causes
Symptoms
Patients with a cerebellar hemangioblastoma typically develop symptoms related to the enlarging tumor and cyst putting pressure on the cerebellum or causing hydrocephalus (excess cerebrospinal fluid).
Common symptoms include:
- Headaches
- Dizziness
- Problems with coordination and balance
- Visual disturbances
- Weakness or numbness in the limbs.
If the tumor causes hydrocephalus (excess cerebrospinal fluid), symptoms may include:
- Nausea and vomiting
- Gait instability
- Confusion or changes in mental status
Causes
The exact cause of hemangioblastomas is not well understood. However, it is believed that these tumors develop as a result of abnormal growth and proliferation of the cells that form the blood vessels.
In some cases, hemangioblastomas are associated with a genetic condition called Von Hippel-Lindau disease, which is characterized by the formation of tumors in various organs including the brain and spinal cord.
When to See a Doctor
Seek prompt medical attention if you experience persistent headaches, unexplained balance problems, sudden vision changes, or neurological symptoms that interfere with daily activities. Early diagnosis can help prevent serious complications from tumor growth or hydrocephalus.
Hemangioblastoma Diagnosis
Diagnosing hemangioblastomas involves a combination of imaging studies, such as magnetic resonance imaging (MRI) or computed tomography (CT) scans, to visualize the tumor and assess its size, location, and relationship with nearby structures. The solid part of the hemangioblastoma (mural nodule) enhances intensely after contrast administration on both MRI and CT while the associated cyst (fluid) does not enhance.
Additional tests, including angiography, may be performed to evaluate the blood supply to the tumor.
Any patient diagnosed with a hemangioblastoma should have a thorough evaluation for Von Hippel-Lindau disease.
Hemangioblastoma Treatmentrn& Outcomes
Treatment Options
The primary treatment for hemangioblastomas is surgical resection, which involves removing the tumor while preserving surrounding healthy brain tissue. Symptomatic cerebellar or brainstem hemangioblastomas are typically treated by surgical removal through a sub-occipital or retromastoid craniotomy.
The goal of surgery is to achieve complete removal of the tumor and alleviate any compression or pressure on nearby structures. However, the location and size of the tumor can sometimes make complete resection challenging, and in such cases, partial removal or debulking may be performed to relieve symptoms and reduce tumor size. In our practice, complete removal of the enhancing tumor nodule is accomplished in 80-90% of patients.
For partially removed tumors, radiosurgery or stereotactic radiotherapy is relatively effective. Radiation therapy may be considered as an adjunct to surgery in cases where complete resection is not feasible or when there is a risk of tumor recurrence. The use of targeted therapies or embolization procedures to reduce blood supply to the tumor may be considered in select cases, especially when associated with VHL disease.
In select cases, embolization may be performed before surgery to reduce the tumor’s blood supply, particularly for large or complex lesions.
Patient Outcomes
With complete surgical removal, outcomes are excellent, and recurrence is uncommon in sporadic cases. In patients with VHL disease, ongoing monitoring is necessary because new tumors may form over time. Long-term prognosis is generally very good with appropriate treatment and follow-up.
Managing Hemangioblastoma
Regular follow-up is essential for individuals with hemangioblastomas, as these tumors have the potential to recur or develop new lesions over time. Imaging studies and clinical evaluations are typically performed at regular intervals to monitor for any signs of tumor growth or recurrence. For patients with VHL disease, a multidisciplinary approach—including genetic counseling and screening for other tumors—is recommended.
Meet our Expert Specialists & Surgeons
Experience Compassionate, Expert Care
At Pacific Neuroscience Institute, our team combines advanced microsurgical and minimally invasive techniques with decades of experience in brain and spinal cord tumor surgery. Using high-definition imaging, precision navigation, and intraoperative monitoring, we strive to make hemangioblastoma surgery safer, less invasive, and more effective—while providing the personalized, compassionate care every patient deserves.
Learn More About Hemangioblastoma
The prognosis is excellent for most patients after complete surgical removal. Sporadic hemangioblastomas rarely recur, but patients with VHL disease require lifelong monitoring for new tumors.
Because hemangioblastomas are benign, the long-term survival rate is very high—close to 100%—when treated appropriately.
No. Hemangioblastomas are benign and do not spread to other parts of the body. However, they can cause serious neurological problems if left untreated due to pressure on the brain or spinal cord.
The cerebellum is the most common location, followed by the spinal cord and brainstem.
A hemangioma is a common, usually harmless growth of blood vessels often found in the skin or liver. A hemangioblastoma is a rare, benign tumor of the CNS that arises from blood vessel–forming cells and typically occurs in the brain or spinal cord.
Yes. In most cases, complete surgical removal is curative. Patients with VHL disease may develop new tumors over time, requiring additional treatment.
Hemangioblastomas typically grow slowly, but their cystic component can enlarge more quickly, leading to rapid onset of symptoms.
Hemangioblastomas are strongly associated with Von Hippel–Lindau disease, a genetic syndrome involving tumors in multiple organs.
Resources
Get Expert Care from Leading Specialists
If you or a loved one has been diagnosed with a hemangioblastoma, our team at Pacific Neuroscience Institute is here to provide advanced treatment with compassion and skill.